Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Recruiting
Who can join
Ages 11 to 18 · All sexes
Full eligibility criteria
Inclusion: * Nationwide Children's Hospital patients * Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent * Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days) * Resides with primary caregiver who has legal authority to consent to research participation Exclusion: * Suicide attempt in the past 3 months * Diagnosis of Bipolar Disorder or Psychosis * Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months * Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season * Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year * Body Mass Index \> 40 * Daytime symptoms of Restless Leg Syndrome * Diagnosis of Narcolepsy * Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years * Significant substance use in the past month * Currently receiving sleep disorder services from a sleep clinic * Inability to speak/read English adequately to understand and complete study consent and procedures * No access to a telephone or internet-connecting device * Sibling already in the study
About the study
This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.
What is being tested
- TAILOR (behavioral)
- Enhanced Usual Care (other)
Sponsor: Jeff Bridge · Participants: 235 · Started: Oct 20, 2022
Contact the study team
- Elizabeth Cannon, MA, MS · Phone: 614-355-0578
- Kendra Heck, MPH · Phone: 614-355-3433
Official record on ClinicalTrials.gov — NCT05390918
Locations in the U.S.
| Ohio | Nationwide Children's Hospital, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.